Информация предназначена только для профессионалов в области здравоохранения.
Вы можете зайти как пользователь социальных сетей
ФГАОУ ВО «Первый Московский государственный медицинский университет им. И.М. Сеченова» Минздрава России (Сеченовский Университет), Москва, Россия aapilipovich@mail.ru
Список исп. литературыСкрыть список 1. Jakobsson U. The epidemiology of chronic pain in a general population: results of a survey in southern Sweden. Scand J Rheumatol 2010; 39 (5): 421–9. DOI: 10.3109/03009741003685616 2. Jones GT, Atzeni F, Beasley M et al. The Prevalence of Fibromyalgia in the General Population: A Comparison of the American College of Rheumatology 1990, 2010, and Modified 2010 Classification Criteria. Arthritis Rheumatol 2015; 67 (2): 568–75. DOI: 10.1002/art.38905 3. Queiroz LP. Worldwide epidemiology of fibromyalgia. Curr Pain Headache Rep 2013; 17: 356. DOI: 10.1007/s11916-013-0356-5 4. Choy E, Perrot S, Leon T et al. A patient survey of the impact of fibromyalgia and the journey to diagnosis. BMC Health Serv Res 2010; 10: 102. DOI: 10.1186/1472-6963-10-102 5. Briones-Vozmediano E, Vives-Cases C, Ronda-Perez E et al. Patients’ and professionals’ views on managing fibromyalgia. Pain Res Manag 2013; 18: 19–24. DOI: 10.1155/2013/742510 6. Bazzichi L, Giacomelli C, Consensi A et al. One year in review 2020: fibromyalgia. Clin Exp Rheumatol 2020; 38 (1): 3–8. https://www. clinexprheumatol.org/abstract.asp?a=15345 7. Dong-Jin Park, Shin-Seok Lee New insights into the genetics of fibromyalgia. Korean J Intern Med 2017; 32 (6): 984–95. DOI: 10.3904/kjim.2016.207PMCID 8. De Lima LO, Zicarelli CAM, Matsumura AS et al. Lower limb muscle strength and serotonin receptor gene polymorphism as factors associated in women with fbromyalgia. Adv Rheumatol 2019; 59: 59. DOI: 10.1186/s42358-019-0101-9 9. Staud R, Vierck CJ, Cannon RL et al. Abnormal sensitization and temporal summation of second pain (wind-up) in patients with fibromyalgia syndrome. Pain 2001; 91 (1–2): 165–75. DOI: 10.1016/s0304-3959(00)00432-2 10. Evdokimov D, Frank J, Klitsch A et al. Reduction of skin innervation is associated with a severe fbromyalgia phenotype. Ann Neurol 2019; 86: 504–16. DOI: 10.1002/ana.25565 11. Trouvin AP, Perrot S. New concepts of pain. Best Pract Res Clin Rheumatol 2019; 33: 101415. DOI: 10.1016/j.berh.2019.04.007 12. Fitzcharles MA, Perrot S, Hauser W. Comorbid fibromyalgia: A qualitative review of prevalence and importance. Eur J Pain 2018; 22: 1565–76. DOI: 10.1002/ejp.1252 13. Treede RD, Rief W, Barke A et al. Chronic pain as a symptom or a disease: the IASP Classification of Chronic Pain for the International Classification of Diseases (ICD-11). Pain 2019; 160 (1): 19–27. DOI: 10.1097/j.pain.0000000000001384 14. Wolfe F, Clauw DJ, Fitzcharles MA et al. 2016 revisions to the 2010/2011 fibromyalgia diagnostic criteria. Semin Arthritis Rheum 2016; 46 (3): 319–29. DOI: 10.1016/j.semarthrit.2016.08.012 15. Hauser W, Sarzi-Puttini P, Fitzcharles M-A. Fibromyalgia syndrome: under-, over- and misdiagnosis. Clin Exp Rheumatol 2019; 37 (Suppl. 119): S90-7. 16. Walitt B, Katz RS, Bergman MJ et al. Three-Quarters of Persons in the US Population Reporting a Clinical Diagnosis of Fibromyalgia Do Not Satisfy Fibromyalgia Criteria: The 2012 National Health Interview Survey. PLoS One 2016; 11: e0157235. DOI: 10.1371/journal. pone.0157235 17. Hauser W, Perrot S, Sommer C et al. Diagnostic confounders of chronic widespread pain: not always fibromyalgia. Pain Rep 2017; 2: e598. DOI: 10.1097/PR9.0000000000000598 18. Macfarlane GJ, Kronisch C, Dean LE et al. EULAR revised recommendations for the management of fibromyalgia. Ann Rheum Dis 2017; 76 (2): 318–28. DOI: 10.1136/annrheumdis-2016-209724 19. Maffei ME. Fibromyalgia: Recent Advances in Diagnosis, Classification, Pharmacotherapy and Alternative Remedies. Int J Mol Sci 2020; 21(21): 7877. DOI: 10.3390/ijms21217877